Key result
Nonalcoholic fatty liver disease was independently associated with a increased risk of ventricular tachycardia and sinus arrest in patients with NSTEMI.
Why the study?
The relationship between nonalcoholic fatty liver disease and malignant arrhythmia in patients with non-ST-segment elevation myocardial infarction remains unclear.
Does the presence of NAFLD increase the risk of ventricular tachycardia and sinus arrest in patients with NSTEMI?
Cross-Sectional (n=358)
No
Does the presence of NAFLD increase the risk of ventricular tachycardia and sinus arrest in patients with NSTEMI?
Answers are grounded in this paper and cite their sources.
Nonalcoholic fatty liver disease is an independent risk factor for malignant arrhythmias, including ventricular tachycardia and sinus arrest, in patients following NSTEMI.
Nonalcoholic fatty liver disease (NAFLD) is an emerging driver of cardiac arrhythmias. However, the relationship between NAFLD and malignant arrhythmia in non-ST-segment elevation myocardial infarction (NSTEMI) patients is still unclear.In this study, 358 NSTEMI inpatients were enrolled. They all received 24-hour Holter monitoring after percutaneous coronary intervention. All inpatients were divided into two groups: the non-NAFLD group (236 cases, 65.9%) and the NAFLD group (122 cases, 34.1%). Compared with the non-NAFLD group, the NAFLD group had a significantly higher incidence of PVCs/hour > 5 (premature ventricular complexes, 32.0% versus 9.3%, P < 0.001), ventricular tachycardia (VT, 22.1% versus 5.9%, P < 0.001), and sinus arrest (SA, 7.4% versus 1.3%, P = 0.002). We found that NAFLD was closely associated with the occurrence of VT [unadjusted odds ratio (OR) 4.507, 95% confidence interval (CI) 2.263-8.974, P < 0.001] and SA (OR 6.186, 95%CI 1.643-23.291, P = 0.007). After adjusting for age, sex, body mass index, and other confounding factors, the above differences were still statistically significant (VT: OR 4.808, 95%CI 2.254-10.253, P < 0.001; SA: OR 9.589, 95%CI 2.027-45.367, P = 0.004).NAFLD is associated with the occurrence of VT and SA in NSTEMI patients. It indicates that NAFLD might be a risk factor for malignant arrhythmias in post-NSTEMI patients.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2022) conducted a cross-sectional in Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) (n=358). Nonalcoholic fatty liver disease (NAFLD) vs. Non-NAFLD was evaluated on Ventricular tachycardia (VT) (OR 4.808, 95% CI 2.254-10.253, p=<0.001). Nonalcoholic fatty liver disease was independently associated with a increased risk of ventricular tachycardia and sinus arrest in patients with NSTEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: